Bcl-2 sustains hormetic response by inducing Nrf-2 nuclear translocation in L929 mouse fibroblasts

Free Radical Biology and Medicine

Volumn 49, Issue 7, 2010, Pages 1192-1204

  Luna López, Armando ^a   Triana Martínez, Francisco ^a   López Diazguerrero, Norma E ^a   Ventura Gallegos, José L ^b,c   Gutiérrez Ruiz, María C ^a   Damián Matsumura, Pablo ^a   Zentella, Alejandro ^b,c   Gómez Quiroz, Luis E ^a   Königsberg, Mina ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

GCS; Bcl 2; Free radicals; GST; Hormesis; Nrf 2; Oxidative stress

Indexed keywords

COMPLEMENTARY DNA; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; MESSENGER RNA; NUCLEAR FACTOR; NUCLEAR FACTOR ERYTHROID DERIVED 2 LIKE 2; PROTEIN BCL 2; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; HORMESIS; LUNG FIBROBLAST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BENZOPYRANS; CELL LINE; CELL NUCLEUS; CYTOPROTECTION; FIBROBLASTS; HYDROGEN PEROXIDE; MICE; NF-E2-RELATED FACTOR 2; NITRILES; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION;

EID: 77956171683     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.07.004     Document Type: Article

References (67)

1. Calabrese E.J., Bachmann K.A., Bailer A.J., Bolger P.M., Borak J., Cai L., Cedergreen N., Cherian M.G., Chiueh C.C., Clarkson T.W., Cook R.R., Diamond D.M., Doolittle D.J., Dorato M.A., Duke S.O., Feinendegen L., Gardner D.E., Hart R.W., Hastings K.L., Hayes A.W., Hoffmann G.R., Ives J.A., Jaworowski Z., Jonson T.E., Jonas W.B., Kaminski N.E., Keller J.G., Klaunig J.E., Knudsen T.B., Kozumbo W.J., Lettieri T., Liu S.Z., Maisseu A., Maynard K.I., Masoro E.J., McClellan R.O., Mehendale H.M., Mothersill C., Newlin D.B., Nigg H.N., Oehme F.W., Phalen R.F., Philbert M.A., Rattan S.I., Riviere J.E., Rodricks J., Sapolsky R.M., Scott B.R., Seymour C., Sinclair D.A., Smith-Sonneborn J., Snow E.T., Spear L., Stevenson D.E., Thomas Y., Tubiana M., Williams G.M., Mattson M.P. Biological stress response terminology. Toxicol. Appl. Pharmacol. 2007, 222:122-128.
2. Calabrese E.J. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson Law are manifestations of hormesis. Ageing Res. Rev. 2008, 7:8-20.
3. Mattson M.P. Hormesis defined. Ageing Res. Rev. 2008, 7:1-7.
4. Hoffmann G.R. A perspective on the scientific, philosophical, and policy dimensions of hormesis. Dose-Response 2009, 7:1-51.
5. Rattan S.I.S., Fernandes R.A., Demirovic D., Dymek B., Lima C.F. Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation. Dose-Response 2009, 7:90-103.
6. Calabrese E.J., Baldwin L.A. Toxicology rethinks its central belief. Nature 2003, 421:691-692.
7. Rattan S.I.S. Increased molecular damage and heterogeneity as the basis of aging. Biol. Chem. 2008, 389:267-272.
8. Mathers J., Fraser J.A., McMahon M., Saunders R.D., Hayes J.D., McLellan L.I. Antioxidant and cytoprotective responses to redox stress. Biochem. Soc. Symp. 2004, 71:157-176.
9. Sen-Yung H., Chih-Yun H., Jung-Ru H., Chiung-Liang L., Shao-Jung L., Ying-Ching C., Hui-Yu H. Identifying apoptosis-evasion proteins/pathways in human hepatoma cells via induction of cellular hormesis by UV irradiation. J. Proteome Res. 2009, 8:3977-3986.
10. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26:1324-1337.
11. Youle R.J., Strasser A. The Bcl-2 protein family: opposing activities that mediate cell death. Nat. Rev. 2008, 9:47-59.
12. Susnow N., Zeng L., Margineantu D., Hockenbery D.M. Bcl-2 family proteins as regulators of oxidative stress. Semin. Cancer Biol. 2009, 19:42-49.
13. Tsujimoto Y., Ikegaki N., Croce C.M. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987, 2:3-7.
14. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
15. Kowaltowski A.J., Fenton R.G., Fiskum G. Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress. Free Radic. Biol. Med. 2004, 37:1845-1853.
16. Meredith M.J., Cusick C.L., Soltaninassab S., Sekhar K.S., Lu S., Freeman M.L. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. Biochem. Biophys. Res. Commun. 1998, 248:458-460.
17. Zimmermann A.K., Loucks F.A., Schroeder E.K., Bouchard R.J., Tyler K.L., Linseman D.A. Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J. Biol. Chem. 2007, 282:29296-29304.
18. Lee M.H., Hyun D.H., Marshall K.A., Ellerby L.M., Bredesen D.E., Jenner P., Halliwell B. Effect of overexpression of Bcl-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses and the proteasome. Free Radic. Biol. Med. 2001, 31:1550-1559.
19. Vairo G., Soos T., Upton T.M., Zalvide J., Decaprio J.A., Ewen M.E., Koff A., Adams J.M. Bcl-2 retards cell cycle entry through p27Kip1, pRb relative p130, and altered E2F regulation. Mol. Cell. Biol. 2000, 20:4745-4753.
20. López-Diazguerrero N.E., López-Araiza H., Conde-Pérezprina J.C., Bucio L., Cárdenas M.C., Ventura J.L., Covarrubias L., Gutiérrez-Ruiz M.C., Zentella A., Königsberg M. Bcl-2 protects against oxidative stress while inducing premature senescence. Free Radic. Biol. Med. 2006, 40:1161-1169.
21. Forman H.J., Fukuto J.M., Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. Cell Physiol. 2004, 287:C246-C256.
22. Jones P.D. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 2008, 295:C849-C868.
23. Lee J.S., Surh Y.J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005, 224:171-184.
24. Moi P., Chan K., Asunis I., Cao A., Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl Acad. Sci. USA 1994, 91:9926-9930.
25. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
26. Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 2009, 47:1304-1309.
27. Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284:13291-13295.
28. Kensler T.W., Wakabayashi N., Visual S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2009, 47:89-116.
29. Jain A.K., Mahajan S., Jaiswal A.K. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J. Biol. Chem. 2008, 283:17712-17720.
30. Kobayashi A., Kang M., Watai Y., Tong K.I., Shibata T., Uchida K., Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap. Mol. Cell. Biol. 2006, 26:221-229.
31. Tong K.I., Kobayashi A., Katsuoka F., Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 2006, 387:1311-1320.
32. Pi J., Bai Y., Reece J.M., Williams J., Liu D., Freeman M.L., Fahl W.E., Shugar D., Liu J., Qu W., Collins S., Waalkes M.P. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 2007, 42:1797-1806.
33. Jain A.K., Jaiswal A.K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 2006, 281:12132-12142.
34. Maher J., Yamamoto M. The rise of antioxidant signaling-the evolution and hormetic actions of Nrf2. Toxicol. Appl. Pharmacol. 2010, 244:4-15.
35. Steinman H.M. The Bcl-2 oncoprotein functions as a pro-oxidant. J. Biol. Chem. 1995, 270:3487-3490.
36. Seyfried J., Evert B.O., Schwarz C.S., Schaupp M., Schultz J.B., Klockgether T., Wüllner U. Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status. Free Radic. Biol. Med. 2003, 34:1517-1530.
37. Mendoza-Milla C., Machuca-Rodríguez C., Córdova-Alarcón E., Estrada-Bernal A., Toledo-Cuevas E.M., Martínez-Martínez E., Zentella-Dehesa A. NF-kappaB activation but not PI3K/Akt is required for dexamethasone dependent protection against TNF-alpha cytotoxicity in L929 cells. FEBS Lett. 2005, 579:3947-3952.
38. Fariss M.W., Reed D.J. High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Meth. Enzymol. 1987, 143:101-109.
39. Gómez-Quiroz L.E., Factor V.M., Kaposi-Novak P., Coulouarn C., Conner E.A., Thorgeirsson S.S. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis. J. Biol. Chem. 2008, 283:14581-14589.
40. Wang L., Hirayasu K., Ishisawa M., Kobayash Y. Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated NaI and SDS. Nucleic Acids Res. 1994, 22:1774-1775.
41. Matos H.R., Capelozzi V.L., Gomes O.F., Di Mascio P., Medeiros M.H.G. Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitriloacetate. Arch. Biochem. Biophys. 2001, 396:171-177.
42. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA. DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-537.
43. Wang J.L., Liu D., Zhang Z.J., Shan S., Han X., Srinivasula S.M., Croce C.M., Alnemri E.S., Huang Z. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl Acad. Sci. USA 2000, 97:7124-7129.
44. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
45. Kweon M., Adhami V.M., Lee J.S., Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J. Biol. Chem. 2006, 281:33761-33772.
46. Bass D.A., Parce J.W., Dechatelet L.R., Szejdr P., Seed M.C., Thomas M. Flow cytometry studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 1983, 130:1910-1917.
47. Cathcart R., Schwiers E., Ames B.N. Detection of picomole levels of hydroperoxides using a fluorescent dicholorofluorescein assay. Meth. Enzymol. 1984, 105:352-358.
48. Manero F., Gautier F., Gallenne T., Cauquil N., Gree D., Cartron P.F., Grée D., Cartron P.F., Geneste O., Grée R., Vallette F.M., Juin P. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res. 2006, 66:2757-2764.
49. Kowaltowski A.J., Fiskum G. Redox mechanisms of cytoprotection by Bcl-2. Antioxid. Redox Signaling 2005, 7:508-514.
50. Janowiak B.E., Hayward M.A., Peterson F.C., Volkman B.F., Griffith O.W. Gamma-glutamylcysteine synthetase-glutathione synthetase: domain structure and identification of residues important in substrate and glutathione binding. Biochemistry 2006, 45:10461-10473.
51. Townsend D.M., Findlay V.L., Tew K.D. Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Meth. Enzymol. 2005, 401:287-307.
52. Lluis J.M., Morales A., Blasco C., Colell A., Mari M., Garcia-Ruiz C., Fernandez-Checa J.C. Critical role of mitochondrial glutathione in the survival of hepatocytes during hypoxia. J. Biol. Chem. 2005, 280:3224-3232.
53. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., Wolf C.R., Cavin C., Hayes J.D. The Cap'n'Collar basic leucine zipper transcription factor Nrf-2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 2001, 61:3299-3307.
54. Niture S.K., Kaspar J.W., Shen J., Jaiswal A.K. Nrf2 signaling and cell survival. Toxicol. Appl. Pharmacol. 2010, 224:37-42.
55. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res. 2005, 1057:57-64.
56. Métrailler-Ruchonnet I., Pagano A., Carnesecchi S., Ody C., Donati Y., Barazzone-Argiroffo C. Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway. Free Radic. Biol. Med. 2007, 42:1062-1074.
57. Wisel S., Khan M., Kuppusamy M.L., Mohan I.K., Chacko S.M., Rivera B.K., Sun B.C., Hideg K., Kuppusamy P. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2, 3, 4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J. Pharmacol. Exp. Ther. 2009, 329:543-550.
58. Furukawa K., Estus S., Fu W., Mark R.J., Mattson M.P. Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. J. Cell Biol. 1997, 136:1137-1149.
59. Oliver L., Mahe B., Grée R., Vallette F.M., Juin P. HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells. Leuk. Res. 2007, 31:859-863.
60. Zimmermann A.K., Loucks F.A., Le S.S., Butts B.D., Flores-McClure M.L., Bouchard R.J., Heidenreich K.A., Linseman D.A. Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl-2/Bcl-x(L) versus induction of the BH3-only protein Bim. J. Neurochem. 2005, 94:22-36.
61. Itoh K., Tong K.I., Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 2004, 36:1208-1213.
62. Levy S., Jaiswal A.K., Forman H.J. The role of c-Jun phosphorylation in EpRE activation of phase II genes. Free Radic. Biol. Med. 2009, 47:1172-1179.
63. Celli A., Que F.G., Gores G.J., LaRusso N.F. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am. J. Physiol. 1998, 275:G749-G757.
64. Howard A.N., Bridges K.A., Meyn R.E., Chandra J. ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress. Cancer Chemother. Pharmacol. 2009, 65:41-54.
65. Garcia-Ruiz C., Fernandez-Checa J.C. Redox regulation of hepatocyte apoptosis. J. Gastroenterol. Hepatol. 2006, 21:3-6.
66. Giménez-Bonafé P., Tortosa A., Pérez-Tomás R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr. Cancer Drug Targets 2009, 9:320-340.
67. Kensler T.W., Wakabayashi N. Nrf2: friend or foe for chemoprevention?. Carcinogenesis 2010, 31:90-99.